Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment or prepayment of borrowings
A portion of the net proceeds from the fresh issue will be used to repay or prepay, in full or in part, certain outstanding borrowings of the company.
General corporate purposes
The balance of the net proceeds, after funding debt repayment and issue-related expenses, will be used for general corporate purposes.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Founded in 1996 and headquartered in Bengaluru, Indo-MIM Limited is a global precision engineering company specializing in Metal Injection Molding (MIM) technology. The company designs, engineers, and manufactures complex, high-precision metal and ceramic components for demanding industrial applications worldwide. Its core capabilities integrate product design, tooling, molding, debinding, sintering, secondary machining, and surface finishing under a unified operational model. Indo-MIM operates fifteen manufacturing plants across India, the United States, the United Kingdom, and Mexico, delivering custom-engineered parts to clients across more than fifty countries. The business serves a diversified mix of end markets, including automotive systems, aerospace, defense, medical instruments, oil and gas, and consumer goods. In addition to metal injection molding, the company offers investment casting, ceramic injection molding, precision CNC machining, and metal additive manufacturing services. Supported by an in-house tool design center and metallurgical research facilities, the enterprise develops specialized powder formulations and custom tooling solutions for complex component geometries. With a global supply network and multi-site manufacturing footprint, Indo-MIM has established long-term supplier relationships with tier-one systems manufacturers and global original equipment manufacturers across North America, Europe, and Asia-Pacific.
Indo-MIM raised approximately Rs 1,141 crore from its anchor book on 22 July 2026, allotting about 2.35 crore shares to 92 institutional investors at the upper price band of Rs 485 per share. Domestic mutual funds took up roughly 56 percent of the anchor allocation across 23 fund houses, with participation from names such as ICICI Prudential, HDFC, SBI, Kotak Mahindra, Aditya Birla Sun Life, Axis, Bandhan, and UTI. Life insurers, including ICICI Prudential Life and SBI Life, accounted for close to 10 percent, while the remaining allocation went to foreign portfolio investors such as the Government Pension Fund Global, Goldman Sachs India Equity Portfolio, and BlackRock Global Funds.
Source: RHP • Analysis provided for informational purposes
Last Updated: 29 July 2026, 3:05 PM
Long operating track record
The company has been active in metal injection molding and precision engineering for more than two and a half decades, giving it deep process know-how built up across multiple product generations.
Integrated manufacturing model
It handles the full production chain in-house, from mold design and tooling through molding, finishing and final assembly, reducing dependence on external vendors at each stage.
Diversified end-market exposure
Its component base spans automotive, defense, medical devices, aerospace and consumer products, which limits reliance on any single industry cycle.
Broad export footprint
The company ships to customers in more than fifty countries, reflecting a globally diversified revenue base rather than concentration in the domestic market.
Diverse process technology
Beyond metal injection molding, it operates ceramic injection molding, investment casting, precision machining and metal 3D printing lines, letting it serve a wider range of component specifications.
Customer concentration
A meaningful share of revenue comes from a small number of large customers, so reduced orders from any one of them could hurt results.
Export and currency exposure
A large part of revenue is generated overseas, exposing the business to foreign currency movements and demand conditions in the economies it exports to.
Operational concentration risk
Production runs out of a limited number of manufacturing sites, so an unplanned disruption at any one facility could affect output and deliveries.
MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.
Raw material and import dependence
The business relies on imported and commodity-linked raw materials, leaving margins exposed to price swings and supply availability.
Customer pricing pressure
Large customers can negotiate down prices over time, which can compress margins even as volumes grow.